Trials / Completed
CompletedNCT01286805
Lumbar Plexus Block for Postoperative Pain Control After Hip Arthroscopy. A Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 83 (actual)
- Sponsor
- Hospital for Special Surgery, New York · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether the use of a lumbar plexus block for arthroscopic hip surgery is superior to oral and intravenous opioid pain medications alone in treating pain. In addition, the study will examine whether lumbar plexus blocks reduce the total amount of pain medication needed, and therefore reduce the side effects of these medicines and increase patient satisfaction. It is hypothesized that addition of the lumbar plexus block will significantly reduce patients' postoperative pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Lumbar Plexus Blockade | The lumbar plexus block will be dosed with 30 milliliters of 0.25% bupivacaine with 1:200,000 epinephrine |
| PROCEDURE | Control | The control group will receive only a combined spinal-epidural. |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2010-10-01
- Completion
- 2011-05-01
- First posted
- 2011-01-31
- Last updated
- 2013-06-05
- Results posted
- 2013-06-05
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01286805. Inclusion in this directory is not an endorsement.